Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | Billing Requirements for Multiple Births for Professional ProvidersPayerPolicy · AMERIHEALTH-COMMERCIAL-00-10-38 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located Within a Facility or on a Facility CampusPayerPolicy · AMERIHEALTH-COMMERCIAL-00-10-39 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Bevacizumab (Avastin) and Related Biosimilars For Oncologic UsePayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-66 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Betibeglogene Autotemcel [Beti-Cel (ZYNTEGLO)]PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-89 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Beremagene Geperpavec (Vyjuvek)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-10 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Belimumab (Benlysta) for Intravenous UsePayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-99 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Belantamab mafodotin-blmf (Blenrep)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-53 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Bariatric SurgeryPayerPolicy · AMERIHEALTH-COMMERCIAL-11-03-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Balloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis or Recurrent Acute RhinosinusitisPayerPolicy · AMERIHEALTH-COMMERCIAL-11-16-06 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Axatilimab-csfr (Niktimvo) for Intravenous UsePayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-34 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Avelumab (Bavencio)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-64 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Autonomic Nervous System TestingPayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-23 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)PayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-29 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Autologous Chondrocyte Implantation (ACI) and Other Cell-based Treatments of Focal Articular Cartilage Lesions (Amerihealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-14-06 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Auricular ProsthesesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-82 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Atidarsagene autotemcel (Lenmeldy)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-24 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-69F-3EEA363016 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Assisted Reproductive Technology for Infertility and Oocyte CryopreservationPayerPolicy · AMERIHEALTH-COMMERCIAL-07-10-06 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-27P-777A0F2EB0 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Asparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-35 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Artificial Intervertebral Cervical Disc Insertion (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-14-19 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaPayerPolicy · AMERIHEALTH-COMMERCIAL-11-05-16M-32EB2A875D | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Applied Behavior Analysis (ABA) for the Treatment of Autism Spectrum Disorder (ASD)PayerPolicy · AMERIHEALTH-COMMERCIAL-14-00-03 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Application and Removal of TattoosPayerPolicy · AMERIHEALTH-COMMERCIAL-11-08-05 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Apos biomechanical shoe systemPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-84 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Apheresis TherapyPayerPolicy · AMERIHEALTH-COMMERCIAL-06-03-04 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ankle-Foot/Knee-Ankle-Foot OrthosisPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-39 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Anifrolumab-fnia (Saphnelo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-82 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint ManagementPayerPolicy · AMERIHEALTH-COMMERCIAL-01-00-12 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Amivantamab-vmjw (Rybrevant) and Amivantamab and hyaluronidase-lpuj (Rybrevant Faspro)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-90 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) MonitoringPayerPolicy · AMERIHEALTH-COMMERCIAL-07-02-21 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ambulatory Blood Pressure Monitoring (ABPM) and Home Blood Pressure Monitoring (HBPM) DevicesPayerPolicy · AMERIHEALTH-COMMERCIAL-07-02-09 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Alpha-1 Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-91 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | AlloMap Molecular Expression Testing for Heart Transplant Rejection (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-29 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Allogeneic Processed Thymus Tissue-agdc (Rethymic)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-88 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Allergy ImmunotherapyPayerPolicy · AMERIHEALTH-COMMERCIAL-07-00-21 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Alglucosidase alfa (e.g., Lumizyme), Avalglucosidase alfa-ngpt (Nexviazyme ), Cipaglucosidase alfa-atga (Pombiliti )PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-72 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Alemtuzumab (Lemtrada)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-22E-7353D6B467 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Air Ambulance ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-12-04-03 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Agalsidase beta (Fabrazyme) and pegunigalsidase alfa-iwxj (Elfabrio)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-69 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Afamitresgene autoleucel (Tecelra)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-32 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ado-Trastuzumab Emtansine (Kadcyla)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-11 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | ADAMTS13, recombinant-krhn (Adzynma)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-21 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Acute Care Facility Inpatient TransfersPayerPolicy · AMERIHEALTH-COMMERCIAL-12-04-04B-5E4D960B3B | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | AcupuncturePayerPolicy · AMERIHEALTH-COMMERCIAL-12-00-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ablation of Lung TumorsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-00-16 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Abatacept (Orencia) for Injection for Intravenous UsePayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-62 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Low-Level Laser TherapyPayerPolicy · AMERIHEALTH-COMMERCIAL-07-00-14 | New policy |
|---|
| Aug 1, 2026 | HealthPartners | Specialty testing: endocrinology – retire 06/30/2026PayerPolicy · HEALTHPARTNERS-CC-ENTRY-290306 | Retired |
|---|
| Aug 1, 2026 | HealthPartners | Satralizumab-mwge (Enspryng) and inebilizumab-cdon (Uplizna) – Minnesota Health Care ProgramsPayerPolicy · HEALTHPARTNERS-CC-ENTRY-231392 | Retired |
|---|